Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

PROVE, our clinical trial on Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture is currently recruiting participants from 13 centres across England, with an additional five centres being set up.

PROVE, our clinical trial on Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture is currently recruiting participants from 13 centres across England, with an additional five centres being set up.

The study has been running for just over a year and aims to discover if physiotherapy can improve life quality and mobility for patients recovering from spine fractures related to their osteoporosis by comparing usual care vs. an exercise based intervention vs. a manual therapy based intervention; it will also look at the cost-effectiveness of offering physiotherapy as a care package.

Each year, 120,000 osteoporosis-related spine fractures occur in the UK; 40 % of patients diagnosed with a vertebral fracture will have constant pain and the majority will have difficulties with activities of daily living. Many of these patients are referred for physiotherapy to help with recovery, but we do not know which type of physiotherapy is most helpful to people.

Lead researcher Dr Karen Barker, of NDORMS and Clinical Director (Musculoskeletal) & Head of Physiotherapy at the Nuffield Orthopaedic Centre says of the study:  “We know that suitable physiotherapy can have a significant impact at improving patients’ function and quality of life. The incidence of osteoporosis and associated spinal problems will continue to increase as our population ages and it is vital that we develop effective treatment strategies to help those patients in pain from this disease. Already, PROVE is the largest physiotherapy trial in osteoporosis and on completion of the trial we are confident we will be in a position to advise patients, clinicians and health care commissioners on the place of physiotherapy in osteoporosis management.”

PROVE is led by the University of Oxford and funded by the NIHR HTA (National Institute of Health Research Health Technology Assessment).

You can read more about PROVE on their website. If you are interested in participating and finding out more about this trial please send an email to prove@ndorms.ox.ac.uk or call 01865223489.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.